CCN2 and prostate cancer: Of the 10 mRNAs that were enriched within cultured tumour‐stroma cell‐derived EVs, and therefore predicted to be elevated in patients with high Gleason prostate cancer, only CTGF mRNA expression was significantly elevated (P = 0.0052) (Figure 5c).